Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.

Tumori - 1 Jan 2015

De Feo Gianfranco, D'Ambrosio Francesca, Palmieri Giada, Perrone Francesco, Ciliberto Gennaro

Abstract excerpt

The Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori "Fondazione G. Pascale" (INT-Pascale) is the largest Clinical Care and Research Cancer Center in Southern Italy. The mission is prevention, diagnosis, and care of cancer and innovative research in oncology. In 2013, INT-Pascale joined the Organisation of European Cancer Institutes (OECI) accreditation and classification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Factors
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Europe

Share to Information Dissemination

Share to Interdisciplinary Communication

Share to Medical Oncology

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 27096270
DOI: 10.5301/tj.5000465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.PMID 27096270Read ↗

The Oncology Research Information Exchange Network (ORIEN) – Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologySemantic proximity Read ↗

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.Semantic proximity Read ↗

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific SocietiesSemantic proximity Read ↗

[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Semantic proximity Read ↗

The Current Landscape of Clinical TrialsSemantic proximity Read ↗

Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity Read ↗

What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.Semantic proximity Read ↗

Real-World Data and Evidence in Lung Cancer: A Review of Recent DevelopmentsSemantic proximity Read ↗

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Semantic proximity Read ↗

Developing Generic Templates to Shape the Future for Conducting Integrated Research Platform TrialsSemantic proximity Read ↗

Twinning for the Armenian research infrastructure on cancer researchSemantic proximity Read ↗

Task Force on Strategic Research Direction: Clinical Science Subgroup key science topics report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.